Research Article
Short-Term Outcomes of Elective High-Risk PCI with Extracorporeal Membrane Oxygenation Support: A Single-Centre Registry
Table 4
Short-term outcomes: PCI with ECMO support (n = 14).
| | Successful revascularization, % (n) | 92.8 (13/14) | | Procedural success, % (n) | 85.7 (12/14) | | Improvement of symptoms or LVEF | 58.3 (7/12) | | In-hospital MACE, % (n) | 28.6 (4/14) | | Death, % (n) | 14.3 (2/14) | | MI, % (n) | 6.7 (1/14) | | TVR, % (n) | 6.7 (1/14) | | Clinical bleeding, % (n) | 14.3 (2/14) | | BARC type 2 | 50.0 (1/2) | | BARC type 3a | 0 (0/2) | | BARC type 3b | 0 (0/2) | | BARC type 3c | 0 (0/2) | | BARC type 4 | 0 (0/2) | | BARC type 5a | 50.0 (1/2) | | BARC type 5b | 0 (0/2) | | MACE within 60 days after discharge, % (n) | 16.7 (2/12) | | Death, % (n) | 16.7 (2/12) | | MI, % (n) | 8.3 (1/12) | | TVR, % (n) | 0 (0/12) | | Post-PCI admission to ICU, % (n) | 28.6 (4/14) |
|
|
ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac events; MI, myocardial infarction; N, number of treated patients; PCI, percutaneous coronary intervention; TVR, target vessel revascularization.
|
